XIMONTH Bee Honey Eye Drops

Manufacturer
Shantou Ximonth Biotechnology Co., Ltd.
Effective date
2025-11-26
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:18:27

Label at a glance#

ProductXIMONTH Bee Honey Eye Drops
Active ingredientHONEY
Label structure12 sections

Storage and handling

Store in a cool and dry place.

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

HONEY

OTC - PURPOSE SECTION

1. Effectively relieve eye dryness and fatigue, improve eye comfort, and keep your eyes fresh at all times.

2. Regular use helps maintain the balance of the eye environment, provides auxiliary support for the daily management of early cataracts and myopia, and promotes stable vision.

3. Helps to immediately relieve the troubles in front of your eyes, and pays more attention to long-term eye health.

OTC - WHEN USING SECTION

1. After cleaning your hands, take a small amount of this product, then raise your head, pull open your lower eyelids, and drop 1-2 drops of care solution into your eyes.

2. Close your eyes lightly and press the corners of your eyes with your fingertips to evenly distribute the liquid.

WARNINGS SECTION

Please keep out of reach of children. Do not swallow.Please clean your hands before use to ensure the best results from the product. Discontinue use if signs of irritation or rash occur. Store in a cool and dry place.

OTC - DO NOT USE SECTION

Discontinue use if signs of irritation or rash occur.

OTC - STOP USE SECTION

Discontinue use if signs of irritation or rash occur.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Please keep out of reach of children. Do not swallow.

STORAGE AND HANDLING SECTION

Store in a cool and dry place.

INACTIVE INGREDIENT SECTION

AQUA、GLYCERIN、PANTHENOL、SODIUM PCA

DOSAGE & ADMINISTRATION SECTION

1. After cleaning your hands, take a small amount of this product, then raise your head, pull open your lower eyelids, and drop 1-2 drops of care solution into your eyes.

2. Close your eyes lightly and press the corners of your eyes with your fingertips to evenly distribute the liquid.

INDICATIONS & USAGE SECTION

1. Effectively relieve eye dryness and fatigue, improve eye comfort, and keep your eyes fresh at all times.

2. Regular use helps maintain the balance of the eye environment, provides auxiliary support for the daily management of early cataracts and myopia, and promotes stable vision.

3. Helps to immediately relieve the troubles in front of your eyes, and pays more attention to

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128XI-B03-0079-01XI-B03-0079-01(1).jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84989-011-01XIMONTH Bee Honey Eye Drops50 mg in 1 BOXLIQUID502

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84989-01184989-011-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XIMONTH Bee Honey Eye DropsGLYCERINShantou Ximonth Biotechnology Co., Ltd.3e69c950-bbbc-5c47-e063-6294a90a070e2025-11-26WarningsExact identifier
ndc (package): 84989-011-01
ndc (product): 84989-011
ndc11 (package): 84989001101
spl id: 448b7c27-e958-71e8-e063-6394a90af88f
spl set id: 3e69c950-bbbc-5c47-e063-6294a90a070e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.